Good evening :)
Place Order
Add to Watchlist

JFL Life Sciences Ltd

JFLLIFE

JFL Life Sciences Ltd

JFLLIFE
Health CarePharmaceuticals
SmallcapWith a market cap of ₹106 cr, stock is ranked 3,014
High RiskStock is 4.57x as volatile as Nifty
32.350.00% (+0.00)
32.350.00% (+0.00)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹106 cr, stock is ranked 3,014
High RiskStock is 4.57x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹106 cr, stock is ranked 3,014
High RiskStock is 4.57x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
—3.000.26%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.496.670.52%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

JFL Life Sciences Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing of pharmaceutical products

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 8.17%, vs industry avg of 9.04%

Constant Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0.01%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 61.54%, vs industry avg of 15.28%

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue31.7830.2032.8634.4844.4747.07—
Raw Materialssubtract28.8126.7228.7630.4933.2638.23—
Power & Fuel Costsubtract0.180.300.190.300.340.48
Employee Costsubtract0.961.250.981.431.832.01
Selling & Administrative Expensessubtract0.130.160.290.560.630.46
Operating & Other expensessubtract0.38-0.130.39-4.552.840.82
Depreciation/Amortizationsubtract0.150.240.280.370.430.44—
Interest & Other Itemssubtract0.751.161.232.081.420.83—
Taxes & Other Itemssubtract0.120.140.200.990.910.50—
EPS0.060.070.100.430.531.00—
DPS0.000.000.000.000.000.08—
Payout ratio0.000.000.000.000.000.08—
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
JFL Life Sciences Ltd32.353.000.26%
Sun Pharmaceutical Industries Ltd46.136.580.73%
Cipla Ltd29.214.490.87%
Mankind Pharma Ltd62.9112.57—

Price Comparison

Compare JFLLIFE with any stock or ETF
Compare JFLLIFE with any stock or ETF
JFLLIFE
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

No institutional holdings trend are available

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding67.47%0.00%0.00%0.00%32.53%

Mar 2023

Sep 2023

Mar 2024

Sep 2024

Shareholding History

SepDec '22MarSepMarSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateSep 13, 2024

Final
Final | Div/Share: ₹0.25

Dividend/Share

₹0.25

Ex DateEx Date

Sep 13, 2024

News & Opinions
Corporate
JFL Life Sciences to convene board meeting

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
JFL Life Sciences to hold board meeting

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 31 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Board of JFL Life Sciences recommends final dividend

JFL Life Sciences announced that the Board of Directors of the Company at its meeting held on 2 August 2024, inter alia, have recommended the final dividend of Rs 0.25 per equity Share (i.e. 2.5%) , subject to the approval of the shareholders.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
JFL Life Sciences announces board meeting date

JFL Life Sciences will hold a meeting of the Board of Directors of the Company on 2 August 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live